honokiol has been researched along with Colitis Gravis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, W; Han, W; Kong, R; Lu, J; Shi, Y; Wang, N; Ye, L | 1 |
| Cai, X; Chen, L; Hong, F; Jiang, X; Li, N; Su, K; Tang, M; Wang, L; Wu, W; Xue, L; Yang, J; Ye, H; Ye, N; Zhang, R; Zhao, M; Zhu, Z | 1 |
| Chen, X; Gu, Z; Li, X; Li, Y; Peng, C; Yu, C; Yu, T; Zhang, M; Zhang, X; Zhou, F; Zhou, L; Zhu, D | 1 |
3 other study(ies) available for honokiol and Colitis Gravis
| Article | Year |
|---|---|
Honokiol alleviates ulcerative colitis by targeting PPAR-γ-TLR4-NF-κB signaling and suppressing gasdermin-D-mediated pyroptosis in vivo and in vitro.
Topics: Allyl Compounds; Animals; Biphenyl Compounds; Colitis, Ulcerative; Colon; Dextran Sulfate; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Phenols; PPAR gamma; Pyroptosis; Signal Transduction; Toll-Like Receptor 4 | 2022 |
Identification of the target protein and molecular mechanism of honokiol in anti-inflammatory action.
Topics: Anti-Inflammatory Agents; Colitis, Ulcerative; Humans; Inflammasomes; Leucine; Lipopolysaccharides; NLR Family, Pyrin Domain-Containing 3 Protein; Shock, Septic | 2023 |
SIRT3 Activator Honokiol Inhibits Th17 Cell Differentiation and Alleviates Colitis.
Topics: Animals; Cell Differentiation; Colitis; Colitis, Ulcerative; Cytokines; Dextran Sulfate; Humans; Interleukin-10; Interleukin-17; Mice; Nuclear Receptor Subfamily 1, Group F, Member 3; RNA, Messenger; Sirtuin 3; T-Lymphocytes, Regulatory; Th17 Cells | 2023 |